Serum albumin (3 month average), categories

    < 3.2 g/dl 3.2-3.4 g/dl 3.5-3.9 g/dl >= 4.0 g/dl
Total N N Weighted % N Weighted % N Weighted % N Weighted %
National sample Month                  
Overall AUG10 3,279 187 5.0% 302 9.0% 1,689 50.6% 1,101 35.3%
SEP10 3,292 192 5.8% 306 9.6% 1,688 50.3% 1,106 34.3%
OCT10 3,297 163 5.1% 318 8.9% 1,630 48.9% 1,186 37.1%
NOV10 3,288 173 5.0% 308 9.3% 1,584 48.1% 1,223 37.6%
DEC10 3,596 190 5.3% 311 8.6% 1,671 46.3% 1,424 39.8%
JAN11 3,518 173 4.8% 306 9.0% 1,647 46.5% 1,392 39.8%
FEB11 3,482 166 4.4% 305 8.1% 1,617 47.1% 1,394 40.4%
MAR11 3,486 168 4.9% 311 8.5% 1,601 46.1% 1,406 40.4%
APR11 3,728 195 5.2% 322 8.2% 1,724 47.2% 1,487 39.4%
MAY11 3,717 186 5.0% 329 8.5% 1,736 46.9% 1,466 39.6%
JUN11 3,646 181 4.9% 322 8.8% 1,713 46.8% 1,430 39.5%
JUL11 3,705 180 4.9% 315 8.1% 1,785 47.7% 1,425 39.2%
AUG11 3,876 206 5.1% 358 8.7% 1,869 48.3% 1,443 37.9%
SEP11 3,847 192 4.9% 367 8.8% 1,827 46.6% 1,461 39.7%
OCT11 3,731 163 4.2% 352 8.4% 1,749 47.0% 1,467 40.5%
NOV11 3,609 179 5.6% 330 8.0% 1,673 46.6% 1,427 39.9%
DEC11 3,639 179 5.1% 333 8.1% 1,613 44.2% 1,514 42.5%
JAN12 3,251 153 5.9% 260 7.0% 1,384 42.1% 1,454 45.0%
FEB12 3,181 146 4.9% 256 7.6% 1,345 42.8% 1,434 44.7%
MAR12 1,710 83 4.1% 160 8.2% 710 38.4% 757 49.3%
APR12 7,314 525 4.1% 881 7.2% 3,448 39.7% 2,460 48.9%
MAY12 8,759 717 5.7% 1,117 7.9% 4,218 43.0% 2,707 43.4%
JUN12 9,323 851 5.9% 1,199 7.3% 4,490 46.2% 2,783 40.6%
JUL12 9,835 964 6.7% 1,342 7.9% 4,729 46.7% 2,800 38.8%
AUG12 10,363 993 4.9% 1,390 9.9% 5,031 47.2% 2,949 38.1%
SEP12 10,557 959 4.6% 1,434 9.7% 5,137 47.8% 3,027 38.0%
OCT12 10,663 980 4.8% 1,432 9.7% 5,207 47.6% 3,044 37.9%
NOV12 10,787 956 5.0% 1,420 9.5% 5,288 46.2% 3,123 39.2%
DEC12 10,893 927 5.5% 1,380 7.7% 5,254 46.1% 3,332 40.7%
JAN13 10,839 907 6.0% 1,360 8.8% 5,212 43.4% 3,360 41.8%
FEB13 10,937 994 6.7% 1,340 9.2% 5,257 45.5% 3,346 38.5%
MAR13 11,136 1,060 6.3% 1,385 9.2% 5,304 45.0% 3,387 39.5%
APR13 11,004 1,035 5.9% 1,385 8.7% 5,208 45.1% 3,376 40.3%
MAY13 10,839 963 5.8% 1,373 7.6% 5,217 46.1% 3,286 40.5%
JUN13 10,940 931 5.7% 1,381 8.3% 5,274 44.3% 3,354 41.7%
JUL13 10,968 908 6.3% 1,378 8.2% 5,329 43.9% 3,353 41.5%
AUG13 10,936 842 5.9% 1,343 9.0% 5,366 43.3% 3,385 41.8%
SEP13 10,831 814 4.9% 1,317 8.4% 5,343 44.6% 3,357 42.1%
OCT13 10,753 822 4.7% 1,340 8.4% 5,173 44.0% 3,418 42.9%
NOV13 10,690 866 5.2% 1,313 8.5% 5,041 42.9% 3,470 43.4%
DEC13 10,752 817 5.1% 1,295 8.1% 5,086 43.1% 3,554 43.6%
JAN14 10,603 799 5.3% 1,270 8.3% 5,005 43.8% 3,529 42.6%
FEB14 10,572 841 5.7% 1,238 8.5% 5,017 43.2% 3,476 42.6%
MAR14 10,443 840 5.7% 1,220 9.2% 4,979 42.0% 3,404 43.1%
APR14 10,251 833 6.2% 1,257 9.1% 4,939 44.5% 3,222 40.1%
MAY14 10,276 855 5.7% 1,343 10.1% 5,076 47.8% 3,002 36.4%
JUN14 10,396 910 5.7% 1,427 10.6% 5,308 52.0% 2,751 31.7%
JUL14 10,491 985 5.8% 1,459 11.5% 5,372 51.0% 2,675 31.7%
AUG14 10,530 922 5.5% 1,468 10.7% 5,490 51.4% 2,650 32.3%
SEP14 10,461 919 5.5% 1,447 10.4% 5,393 48.7% 2,702 35.4%
OCT14 10,616 925 5.4% 1,495 9.0% 5,429 47.6% 2,767 38.0%
NOV14 10,499 1,009 5.2% 1,424 9.4% 5,233 46.5% 2,833 38.9%
DEC14 10,527 1,000 5.4% 1,445 10.0% 5,226 44.0% 2,856 40.7%
JAN15 10,446 943 5.4% 1,426 9.8% 5,204 44.9% 2,873 39.9%
FEB15 10,500 950 5.1% 1,397 8.9% 5,192 44.1% 2,961 41.8%
MAR15 8,341 737 5.9% 1,183 10.4% 4,191 47.3% 2,230 36.4%
APR15 9,378 726 5.4% 1,266 9.7% 4,636 45.6% 2,750 39.3%
MAY15 9,906 837 5.9% 1,321 10.0% 5,011 48.0% 2,737 36.0%
JUN15 10,369 946 6.4% 1,423 10.5% 5,212 47.3% 2,788 35.8%
JUL15 10,736 1,028 6.8% 1,464 10.0% 5,418 48.3% 2,826 35.0%
AUG15 10,807 973 6.2% 1,513 10.5% 5,414 47.5% 2,907 35.7%
SEP15 10,857 979 6.2% 1,497 9.6% 5,480 48.2% 2,901 35.9%
OCT15 10,930 1,005 6.1% 1,492 10.0% 5,505 47.9% 2,928 36.0%
NOV15 11,011 1,065 5.9% 1,509 9.5% 5,488 48.4% 2,949 36.1%
DEC15 11,007 1,009 5.7% 1,460 9.2% 5,488 48.0% 3,050 37.1%
JAN16 10,987 983 5.8% 1,533 10.9% 5,460 48.7% 3,011 34.6%
FEB16 10,968 1,026 7.0% 1,542 11.3% 5,483 50.3% 2,917 31.5%
MAR16 11,178 1,092 7.5% 1,576 12.0% 5,641 52.3% 2,869 28.1%
APR16 11,085 1,045 8.0% 1,539 12.3% 5,640 51.7% 2,861 28.0%
MAY16 11,172 1,071 7.8% 1,548 12.4% 5,729 53.1% 2,824 26.8%
JUN16 11,162 1,125 7.8% 1,591 12.4% 5,764 54.1% 2,682 25.6%
JUL16 10,845 1,155 8.4% 1,580 12.1% 5,665 55.2% 2,445 24.3%
AUG16 10,756 1,097 8.3% 1,617 12.5% 5,688 55.4% 2,354 23.8%
SEP16 10,604 1,022 7.7% 1,636 13.5% 5,678 55.8% 2,268 23.0%
OCT16 10,722 1,025 7.3% 1,710 14.6% 5,725 55.0% 2,262 23.1%
NOV16 10,533 993 6.9% 1,706 14.1% 5,550 55.1% 2,284 23.9%
DEC16 10,568 994 6.8% 1,661 13.9% 5,634 54.9% 2,279 24.4%
JAN17 10,655 1,003 7.0% 1,651 13.6% 5,698 55.7% 2,303 23.7%
FEB17 10,506 1,022 7.3% 1,630 13.7% 5,590 54.9% 2,264 24.0%
MAR17 10,515 1,033 6.6% 1,622 13.9% 5,578 54.0% 2,282 25.6%
APR17 10,306 1,024 7.7% 1,591 13.6% 5,423 54.0% 2,268 24.7%
MAY17 10,454 1,003 7.9% 1,586 13.0% 5,437 53.3% 2,428 25.8%
JUN17 10,545 1,012 7.8% 1,596 12.5% 5,507 54.8% 2,430 24.9%
JUL17 10,566 998 6.9% 1,662 14.0% 5,495 53.1% 2,411 26.0%
AUG17 10,510 952 7.5% 1,640 13.8% 5,581 52.8% 2,337 25.9%
SEP17 10,393 923 7.0% 1,553 13.2% 5,594 53.9% 2,323 26.0%
OCT17 10,527 945 7.6% 1,537 12.6% 5,614 53.2% 2,431 26.7%
NOV17 10,282 926 7.3% 1,473 11.5% 5,421 53.8% 2,462 27.4%
DEC17 10,314 934 7.7% 1,430 11.8% 5,356 51.5% 2,594 28.9%
JAN18 10,387 904 7.6% 1,467 12.1% 5,300 51.2% 2,716 29.1%
FEB18 10,409 898 7.9% 1,484 12.5% 5,301 50.8% 2,726 28.8%
MAR18 6,819 610 9.1% 991 14.6% 3,567 51.4% 1,651 24.8%
APR18 9,569 715 5.6% 1,197 10.3% 5,051 51.2% 2,606 32.8%
MAY18 10,355 810 6.2% 1,367 10.8% 5,501 52.2% 2,677 30.7%
JUN18 10,684 840 6.1% 1,464 11.3% 5,662 52.1% 2,718 30.6%
JUL18 11,129 929 6.6% 1,555 12.5% 5,802 51.3% 2,843 29.6%
AUG18 11,546 995 7.1% 1,588 12.0% 6,003 51.2% 2,960 29.7%
SEP18 11,622 992 6.7% 1,634 12.8% 5,957 50.7% 3,039 29.9%
OCT18 11,645 954 6.3% 1,585 11.8% 5,958 51.5% 3,148 30.5%
NOV18 11,513 872 5.6% 1,537 12.1% 5,913 51.4% 3,191 30.9%
DEC18 11,484 805 5.1% 1,464 11.0% 5,885 50.9% 3,330 33.0%
JAN19 11,433 809 5.3% 1,403 10.2% 5,771 49.7% 3,450 34.8%
FEB19 11,389 849 5.4% 1,319 9.8% 5,755 49.5% 3,466 35.3%
MAR19 11,583 853 5.3% 1,381 9.9% 5,859 49.2% 3,490 35.6%
APR19 11,356 808 5.1% 1,313 9.6% 5,804 49.9% 3,431 35.4%
MAY19 11,354 773 5.1% 1,295 9.2% 5,817 47.9% 3,469 37.7%
JUN19 11,518 743 5.0% 1,336 8.6% 5,908 48.1% 3,531 38.3%
JUL19 12,102 818 5.4% 1,395 8.7% 6,206 47.7% 3,683 38.2%
AUG19 12,295 819 5.2% 1,423 8.8% 6,253 47.7% 3,800 38.3%
SEP19 11,983 804 5.3% 1,352 8.6% 6,140 47.2% 3,687 38.9%
OCT19 12,351 797 4.8% 1,431 8.7% 6,284 46.9% 3,839 39.5%
NOV19 11,995 756 4.3% 1,405 8.8% 6,024 45.6% 3,810 41.3%
DEC19 12,189 784 4.3% 1,383 8.3% 6,080 45.6% 3,942 41.8%
JAN20 12,094 821 4.7% 1,347 7.9% 5,974 44.8% 3,952 42.6%
FEB20 12,087 862 5.1% 1,345 7.8% 6,036 46.7% 3,844 40.4%
MAR20 11,835 809 4.9% 1,368 8.4% 5,887 47.2% 3,771 39.5%
APR20 11,801 823 5.2% 1,314 7.9% 5,966 48.5% 3,698 38.4%
MAY20 11,731 821 5.2% 1,304 8.0% 5,874 47.9% 3,732 38.9%
JUN20 11,516 819 5.0% 1,267 7.7% 5,771 47.9% 3,659 39.4%
JUL20 11,242 776 5.1% 1,210 7.6% 5,633 47.2% 3,623 40.1%
AUG20 8,998 603 4.7% 925 7.4% 4,506 47.5% 2,964 40.4%

Values at each month are based on the average of at least two pre-dialysis measurements obtained within the prior 3 months
Facility sample transitioned from DOPPS 4 to 5 in Jan-Apr 2012 (see "Study Sample and Methods").
Facility sample transitioned from DOPPS 5 to 6 in Mar-Jul 2015 (see "Study Sample and Methods").
Facility sample transitioned from DOPPS 6 to 7 in Feb-May 2018 (see "Study Sample and Methods").
Source: US-DOPPS Practice Monitor, October 2020; http://www.dopps.org/DPM